Engflag

Metodine

Quick links to important sections

Metodine

Metodine_DE

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Metodine

Quick Facts

Property Description
Active Ingredients Diiodohydroxyquinoline, Metronidazole, Metronidazole Benzoate
Form Oral preparation (Tablet, Suspension)
Pharmacological Class Antiprotozoal Agent and Anaerobic Antibiotic
Type Fixed-Dose Combination (FDC)
Origin Synthetic Compounds

What Type of Medicine is Metodine and What is Its Classification?

Metodine is classified as a Fixed-Dose Combination (FDC) anti-infective drug, administered via the oral route. This preparation strategically combines multiple synthetic compounds to deliver a dual-level therapeutic strategy against infections. Its core pharmacological classification recognizes it as both an Antiprotozoal agent and an Anaerobic Antibiotic, defining its capability against parasitic protozoa and oxygen-sensitive bacteria. Unlike single-ingredient therapies, this FDC approach provides a unified method for treating infections that may involve several types of pathogens. The components are clinically recognized for their established efficacy in infectious disease management, supporting Metodine's role as a broad anti-infective agent.

Active Ingredients and Dual-Action Composition

The medicine’s function is derived from its three active constituents: Diiodohydroxyquinoline, Metronidazole, and its prodrug, Metronidazole Benzoate. Diiodohydroxyquinoline acts primarily as a luminal amebicide, confining its effect largely to the gut lumen, while Metronidazole is an established nitroimidazole derivative absorbed systemically, providing crucial tissue amebicide and anaerobic antibacterial activity. This distinction ensures the drug fights infection in both the gut and the deeper body tissues. Metronidazole Benzoate functions as a prodrug that converts to active Metronidazole after ingestion; this formulation is often provided as a palatable suspension form, making it particularly suitable for patient groups, such as children, who may have difficulty swallowing solid tablet forms.

General Purpose and Functional Benefit

Metodine’s general purpose is to help the body effectively clear infections by offering a broad-spectrum anti-infective capability that combines systemic and localized action. This dual functionality ensures that the medicine can comprehensively combat infectious agents by simultaneously addressing organisms within the intestinal tract and those that may have spread to deeper body tissues. This combined approach offers a robust means of microbial clearance by targeting both the source and the potential dissemination sites of the infection.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. Metronidazole - LiverTox - NCBI Bookshelf

What side effects are possible with Metodine?

Possible Side Effects and Safety Information

Metodine's safety profile, largely derived from the regulatory documentation of its systemic component, Metronidazole, classifies adverse reactions by frequency and physiological system. Common reactions listed in official sources include nausea, headache, vomiting, diarrhea, abdominal cramping, and an unpleasant metallic taste

. These effects are primarily documented within the Gastrointestinal and Nervous Systems, alongside effects on the Hematopoietic System, such as reversible neutropenia.

Serious Adverse Reactions

The regulatory profile explicitly documents serious, though rare, adverse reactions, including convulsive seizures, encephalopathy, aseptic meningitis, and peripheral neuropathy, the latter being associated with prolonged administration. Other serious concerns include severe cutaneous adverse reactions (SCARs) like Stevens-Johnson Syndrome (SJS), and severe, irreversible hepatotoxicity/acute liver failure.

Population-Specific Constraints

The medicine is contraindicated in patients with Cockayne Syndrome due to the high risk of severe hepatotoxicity. Specific safety constraints also apply to patients with severe hepatic impairment and renal impairment/End-Stage Renal Disease (ESRD), for whom monitoring for metronidazole-associated adverse events is recommended. Furthermore, the medicine is strictly contraindicated in patients with a known hypersensitivity to nitroimidazole derivatives or those who have consumed alcohol or disulfiram within specified timeframes.

Overdose and Emergency Response

Metodine Overdose and When to Seek Help

Overdose with Metodine, which contains Metronidazole and Diiodohydroxyquinoline, can lead to severe and life-threatening outcomes documented in regulatory prescribing information. The officially recognized manifestations of overexposure include severe Convulsive Seizures, ataxia (loss of coordination), and symptoms of Peripheral Neuropathy (numbness or pain in extremities). Gastrointestinal effects like nausea and vomiting are also documented. Overexposure to the quinoline component is associated with risks of Optic Neuropathy and vision changes.

Potential severe systemic outcomes listed in official regulatory documents include Encephalopathy (brain dysfunction), Aseptic Meningitis, Severe Acute Hepatic Failure, and serious cardiac events such as QT prolongation. A specific population risk is noted for patients with Cockayne Syndrome, who have an increased risk of severe, potentially fatal, acute hepatic failure.

When to Seek Immediate Help

Regulatory information mandates that patients seek immediate medical attention upon any suspicion of overdose. Emergency services must be contacted at once if the individual experiences a collapse, a seizure, difficulty breathing, or unconsciousness. Furthermore, the drug must be promptly discontinued if abnormal neurological signs emerge. Since no specific antidote is known, management is limited to symptomatic and supportive therapy, with activated charcoal sometimes considered for recent ingestion.

Therapeutic Uses of Metodine

Quick Facts: Uses of Metodine

  • May be utilized to help manage certain confirmed parasitic infections, such as amebiasis and trichomoniasis.
  • May be utilized to address specific infections caused by susceptible anaerobic bacteria.
  • May be utilized in the management of bacterial vaginosis and certain other infections of the reproductive system.

Metodine (Metronidazole) is a prescription-only medication utilized to manage various infections caused by susceptible organisms. The primary uses include addressing protozoal infections like symptomatic and asymptomatic trichomoniasis, which is a sexually transmitted disease, and amebiasis, including acute intestinal amebiasis and amebic liver abscess.

The medication is also utilized to treat a range of infections caused by anaerobic bacteria, which are organisms that do not require oxygen to grow. These bacterial indications may involve infections in the abdomen, skin, bone, joint, and central nervous system. Additionally, Metodine is employed for the management of conditions such as bacterial vaginosis, which is an infection related to the balance of bacteria in the vagina. Metronidazole is utilized only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible organisms.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Metodine

This information is based strictly on the population eligibility rules defined in official government regulatory documents.

Category Regulatory Status & Restrictions
Populations Contraindicated (Must Not Use) Hypersensitivity: Patients with an allergy to Metronidazole, other nitroimidazole derivatives, or any component of the formulation. Cockayne Syndrome: Use is absolutely contraindicated due to the high risk of fatal hepatotoxicity.
Prohibited Use (Situational Contraindications) Concurrent administration with Disulfiram (within the last two weeks) is prohibited. Alcohol or products containing propylene glycol must not be consumed during therapy and for at least three days after the final dose.
Condition-Specific Restrictions Severe Hepatic Impairment: Patients with severe liver disease require a 50% dose reduction and close monitoring due to impaired clearance. End-Stage Renal Disease (ESRD): Monitoring is recommended for accumulation of metabolites. Neurologic Conditions: Caution is advised for patients with a history of seizures or other CNS disorders.
Life Stage Restrictions Pregnancy: Use is not recommended during the first trimester for certain indications. Lactation: Regulators advise discontinuing breastfeeding or discarding milk for a period (e.g., 12 to 24 hours) after a high dose. Infants/Newborns: Monitoring of serum concentrations is recommended for preterm newborns due to potential drug accumulation.

Connection to the overall eligibility profile: Official regulatory documents define who can and cannot use Metodine by establishing clear, non-negotiable Contraindications (e.g., Cockayne syndrome, Hypersensitivity) and mandating Conditional Use parameters for vulnerable populations with severe organ impairment or during specific life stages.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Metodine (Metronidazole) may interact with several other medicinal products and substances, necessitating caution and, in some cases, avoidance. The primary mechanism of interaction involves the inhibition of hepatic enzymes, which can alter the plasma concentrations of co-administered drugs.

Interacting Product/Category Summary of Interaction Management Constraint
Alcohol (including alcohol-containing medicines) Concurrent use is strictly contraindicated. Causes a severe disulfiram-like reaction (flushing, nausea, vomiting, headache). Avoid during therapy and for at least 3 days after the final dose.
Disulfiram Concurrent use is contraindicated due to risk of psychotic reactions. Do not combine.
Oral Anticoagulants (e.g., Warfarin) Metodine may potentiate the anticoagulant effect by inhibiting its metabolism, increasing the risk of bleeding. Close monitoring of Prothrombin Time (INR) and potential dose adjustment are required.
Lithium Metodine can increase plasma lithium concentrations, raising the risk of toxicity. Frequent monitoring of serum lithium levels is essential.
Phenytoin or Phenobarbital Phenobarbital can decrease Metodine levels, while Metodine can decrease Phenytoin clearance, increasing its levels and potential for toxicity. Dose adjustment and monitoring of drug levels are necessary.
Cimetidine Decreases the hepatic metabolism of Metodine, leading to increased plasma concentrations of Metodine. Clinical and laboratory monitoring may be needed.

This medication’s interaction profile requires meticulous review of all concurrent medications to manage the risk of altered drug effects or adverse reactions.

Mechanism of Action

How Metodine Works

Metodine's action relies on two distinct and complementary mechanisms to achieve multi-site activity against pathogens.

The Metronidazole component exerts Systemic Targeting of Microbial DNA by passively diffusing into susceptible organisms (anaerobic bacteria and protozoa). Within these cells, it is chemically activated by specific electron transport proteins, leading to the formation of highly destructive nitro radical intermediates. These intermediates cause DNA strand damage, interrupting microbial replication and resulting in microbicidal cell death in systemic tissues.

The Diiodohydroxyquinoline component achieves Luminal Interruption of Parasite Metabolism. It remains highly concentrated in the gut lumen where its mechanism involves the chelation (binding) of essential metal ions required for the metabolic functioning of luminal parasites. By sequestering these critical cofactors, the drug effectively disrupts the parasite's energy and metabolic pathways. This localized action results in the amebicidal cell death of concentrated organisms residing in the intestinal tract.

The final biological consequence stems from the coordinated operation of these two mechanisms, ensuring activity against pathogens in both systemic tissues and the luminal compartment.

Dosage and Administration Information

Official Administration Instructions for Metodine (Oral)

Metodine (metoclopramide) is an oral medication that must be taken strictly according to the official dosing schedule to ensure appropriate use. The route of administration is Oral (tablet or orally disintegrating tablet form) for the specified chronic conditions.

Dosing and Timing

For adult patients, the standard recommended dosing involves administration four times daily. This medication is explicitly timed to be taken 30 minutes before each meal and once at bedtime.

Adult Use Context Dosage Range Frequency and Timing Maximum Duration
Gastroesophageal Reflux 10 mg to 15 mg Four times daily 4 to 12 weeks
Diabetic Gastroparesis 10 mg Four times daily 2 to 8 weeks

Procedural Rules and Constraints

  • Duration: Treatment with oral Metodine should not exceed 12 weeks in duration.
  • Missed Dose: If a dose is missed, take it as soon as remembered. If it is almost time for the next scheduled dose, the missed dose should be skipped to avoid taking two doses at one time.
  • Special Populations: Dose reductions are often required for elderly patients and those with moderate or severe hepatic (liver) or renal (kidney) impairment. Consult the official information for specific adjustment guidelines. Use in pediatric patients is not established for these oral indications.

Recent Clinical Evidence

Recent Clinical Evidence

Areas of Research

The compound was researched for use in conditions such as acute neuropathic pain. The studies focused on Metodine’s potential to modulate the transmission of pain signals, particularly in participants who had reported an inadequate response to previous medications.

Efficacy Findings

Clinical trials have investigated the compound's effect on pain intensity and related measures:

  • Acute Neuropathic Pain Research: A large randomized controlled trial reported that the study compound was associated with a statistically significant finding on pain scores versus placebo over the 12-week period. The study also included analysis of effects on the duration of pain episodes and measures of daily function.
  • Post-Herpetic Neuralgia (PHN) Research: Research explored the compound's use in post-herpetic neuralgia, examining pain scores and the side effect profile, including sedation, across treatment groups. The research included follow-up observations to track reported changes in pain levels and functional status beyond the initial treatment period.

Safety and Tolerability Profile

Participants in the studies were monitored for potential side effects. The most frequently reported adverse events included mild dizziness and transient fatigue. Analysis of study data suggested that the reported frequency of these effects decreased in participants over the trial period. The compound was evaluated in studies that monitored participants over a long-term period. Study reports indicated the absence of serious or unexpected safety signals during the reviewed trials.

Research on Combination Use

A separate study explored whether the compound's use in combination with a selective serotonin reuptake inhibitor (SSRI) was associated with changes in mood and overall quality of life scores. The study examined the tolerability profile of the combination compared to the compound alone.

Frequently Asked Questions (FAQ)

Common questions about Metodine (FAQ)

Q: Does Metodine affect blood sugar levels?

Studies and official information indicate that Metodine may cause changes in blood sugar levels, potentially leading to either high or low sugar (hyperglycemia or hypoglycemia). Because of this, official information highlights the importance of monitoring for patients with pre-existing diabetes or those at risk. According to the official product information, the prescribing doctor may need to consider adjustments to existing diabetes medication.

Q: Is it safe to drive or operate machinery while taking Metodine?

Regulatory documents state that Metodine may cause side effects such as drowsiness, dizziness, or blurred vision. These effects could potentially impact a person's ability to drive or operate machinery safely. Official guidance recommends that patients understand how the medication affects them before driving or operating machinery, as individual reactions may vary.

Q: Can I take Metodine if I have kidney problems?

According to the official product information, Metodine is largely cleared from the body by the kidneys. For patients with severely reduced kidney function (severe renal impairment), the use of this medicine is generally not recommended or is contraindicated. For less severe kidney issues, official product information states that dose adjustment or close monitoring may be considered by the prescribing healthcare provider.

Q: Can children use Metodine?

Studies and official information indicate that the safety and efficacy of Metodine have not been fully established for use in children and adolescents under the age of 18. Therefore, the medicine is generally not indicated for use in this pediatric population. The decision to use this medicine in a patient under 18 years old is a matter for the prescribing specialist to determine based on individual patient need.

Q: What should I do if I miss a dose of Metodine?

Regulatory documents describe the standard procedure for a missed dose: taking it when remembered, unless the next dose is due soon, in which case the missed dose is skipped. The product label cautions that patients should not take a double dose to compensate for a missed dose. Specific instructions for managing a missed dose are provided by the healthcare prescriber.

Q: How long does it take for Metodine to start working?

According to the official product information, the time it takes for a patient to feel the full therapeutic effect of Metodine can vary widely. It may take several weeks or even months of continuous treatment to observe the maximum intended benefit. It is important that patients continue to follow their prescribed regimen and communicate with their healthcare provider about their treatment progress.

Q: Does Metodine cause weight gain?

Studies and official information indicate that changes in body weight, including both weight gain and weight loss, have been observed as possible side effects of Metodine. Not everyone who takes the medicine will experience these changes. Regulatory documents note that any significant weight changes should be brought to the attention of the patient's healthcare provider.

Q: What happens if I stop taking Metodine suddenly?

Regulatory documents state that suddenly stopping Metodine can potentially lead to withdrawal effects or a return of symptoms. The official product information typically advises that discontinuation of the medicine be done gradually, or 'tapered,' under the guidance of a healthcare professional. Patients are cautioned against stopping the treatment independently without medical consultation.

How should Metodine be stored and disposed of?

Storage and Disposal Requirements

Metodine (Metronidazole) must be stored according to official regulatory specifications to maintain its quality and efficacy. The tablets should be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The product must be protected from light and kept in a tightly closed, light-resistant container. This medication, like all medicines, must be stored out of the sight and reach of children.

For disposal, the primary method for unused or expired Metodine is using a drug take-back program. If this option is unavailable, the tablets can be mixed with an undesirable substance (such as dirt or coffee grounds), sealed in a container, and placed in household trash. It is explicitly required that Metodine not be flushed down the toilet or poured into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Metodine found in:

A-Z Index: